High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma

[1]  J. Boyle,et al.  Cancer-associated TERT promoter mutations abrogate telomerase silencing , 2015, eLife.

[2]  Hui Wang,et al.  Acidified bile acids increase hTERT expression via c-myc activation in human gastric cancer cells. , 2015, Oncology reports.

[3]  Chibo Hong,et al.  The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer , 2015, Science.

[4]  Wei Wang,et al.  Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation. , 2015, European journal of cancer.

[5]  J. Cheville,et al.  Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer , 2015, Modern Pathology.

[6]  Ximing J. Yang,et al.  Distinguishing Nested Variants of Urothelial Carcinoma From Benign Mimickers by TERT Promoter Mutation , 2015, The American journal of surgical pathology.

[7]  Liang Cheng,et al.  Contemporary bladder cancer: variant histology may be a significant driver of disease. , 2015, Urologic oncology.

[8]  Ximing J. Yang,et al.  High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins , 2014, Journal of Hematology & Oncology.

[9]  C. Liu,et al.  TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas , 2014, Oncotarget.

[10]  T. Ørntoft,et al.  Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. , 2014, European urology.

[11]  V. Reuter,et al.  Clinical outcome of patients with T1 micropapillary urothelial carcinoma of the bladder. , 2013, The Journal of urology.

[12]  K. Kinzler,et al.  TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. , 2013, Cancer research.

[13]  A. Gutierrez-Hartmann,et al.  Molecular mechanisms of ETS transcription factor-mediated tumorigenesis , 2013, Critical reviews in biochemistry and molecular biology.

[14]  G. Kwon,et al.  Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract , 2013, Journal of Clinical Pathology.

[15]  Miguel Melo,et al.  Frequency of TERT promoter mutations in human cancers , 2013, Nature Communications.

[16]  B. Bochner,et al.  Pathological response to neoadjuvant chemotherapy for muscle‐invasive micropapillary bladder cancer , 2013, BJU international.

[17]  Gary L. Gallia,et al.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.

[18]  D. Schadendorf,et al.  TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.

[19]  K. Kinzler,et al.  Evaluation of DNA from the Papanicolaou Test to Detect Ovarian and Endometrial Cancers , 2013, Science Translational Medicine.

[20]  K. Kinzler,et al.  Detection and quantification of rare mutations with massively parallel sequencing , 2011, Proceedings of the National Academy of Sciences.

[21]  A. Parwani.  Invasive micropapillary urothelial carcinoma of the bladder , 2011 .

[22]  H. Samaratunga,et al.  Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases , 2010, Pathology.

[23]  Andrew H. Beck,et al.  Interobserver Reproducibility in the Diagnosis of Invasive Micropapillary Carcinoma of the Urinary Tract Among Urologic Pathologists , 2010, The American journal of surgical pathology.

[24]  C. Dinney,et al.  The impact of variant histology on the outcome of bladder cancer treated with curative intent. , 2009, Urologic oncology.

[25]  P. Tamboli,et al.  Micropapillary bladder cancer , 2007, Cancer.

[26]  S. Mott,et al.  The Ets transcription factor GABP is required for cell-cycle progression , 2007, Nature Cell Biology.

[27]  A. Lopez‐Beltran,et al.  The 2004 WHO Classification of Bladder Tumors: A Summary and Commentary , 2005, International journal of surgical pathology.

[28]  S. Murakami,et al.  Direct activation of telomerase by EGF through Ets-mediated transactivation of TERT via MAP kinase signaling pathway , 2002, Oncogene.

[29]  Mahul B. Amin,et al.  Micropapillary Variant of Transitional Cell Carcinoma of the Urinary Bladder Histologic Pattern Resembling Ovarian Papillary Serous Carcinoma , 1994, The American journal of surgical pathology.

[30]  D. Raghavan,et al.  Experimental models of histogenesis and tumor cell heterogeneity in bladder cancer. , 1992, Seminars in surgical oncology.